Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 22. März 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8849  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 176963  
   
Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Contieri R, Lazzeri M, Perdonà S, Hurle R.
PMID: 41864760 [PubMed - as supplied by publisher]


Reply to Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Kitamura H, Nishiyama H.
PMID: 41864759 [PubMed - as supplied by publisher]


Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.
Int J Radiat Oncol Biol Phys
Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Guévelou JL.
PMID: 41864432 [PubMed - as supplied by publisher]


Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study.
J Am Acad Dermatol
Chen YJ, Liu WT, Yang CC.
PMID: 41864295 [PubMed - as supplied by publisher]


Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling.
Drug Resist Updat
Zhang H, Liu Y, Zhang W, Guo Y, Lin A, Jin Y, Lu P, Fang Y, Zhang H, Qu L, Luo P, Wu L, Chen Y, Kang X, Wang L, Jiang A.
PMID: 41864072 [PubMed - as supplied by publisher]


Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.
Urologia
Ilktac A, Dogan B, Gevher F, Akcay M, Akbulut H, Ilbey YO.
PMID: 41863856 [PubMed - as supplied by publisher]


Surgical Management of Bone Metastases in Bladder Cancer: A Single-Center Retrospective Study.
Cancer Rep (Hoboken)
Doumanidis P, Tsagkozis P.
PMID: 41863065 [PubMed - indexed for MEDLINE]


PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.
Trials
Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N.
PMID: 41863008 [PubMed - as supplied by publisher]


Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study.
Urol Oncol
Harper A, Khan M, Imm KR, Grubb RL 3rd, Kim EH, Colditz GA, Wolin KY, Kibel AS, Sutcliffe S, Yang L.
PMID: 41862406 [PubMed - as supplied by publisher]


Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective.
Eur Urol Oncol
Duquesne I, Epelbaum I, Prost D, Haberstich M, Suartz CV, Blons H, Taly V, Laurent-Puig P, Horowitz A, Sfakianos JP, Thibault C, Audenet F.
PMID: 41862336 [PubMed - as supplied by publisher]


Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).
Eur Urol Oncol
Gillessen S, Gobat K, Cathomas R, Fischer N, Pereira Mestre R, Hermanns T, Rothschild SI, Mach N, Mingrone W, Ciriolo M, Müller B, Erdmann A, Schär C, Mamot C, Bohanes P, Omlin A, Bastian S, Ribi K, Mazzucchelli L, Barizzi J, Horvath LG, Scheinberg T, Mellor R, Schär S, Lin HM, Lim R, Pollak M, Turco F, Rothermundt C.
PMID: 41862335 [PubMed - as supplied by publisher]


MR ProGradeNet A Multi-Resolution Deep Learning Framework for Automated Prostate Cancer Grading from MRI.
Semin Ultrasound CT MR
Ghag KV, Jagdale J, Vyawahare M.
PMID: 41862143 [PubMed - as supplied by publisher]


Renal cell carcinoma presenting with orbital metastasis as the initial symptom: A case report.
Medicine (Baltimore)
Wang X, Fan Z, Liu R, Qiao Z, Dong W, Shi S, Liu C.
PMID: 41861213 [PubMed - indexed for MEDLINE]


Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain.
PLoS One
Zin CS, Lando S, González-Ortiz A, Mahalingasivam V, Mostafaei S, Ahmad WR, Ahmad Shah MM, Wettermark B, Carrero JJ.
PMID: 41860838 [PubMed - indexed for MEDLINE]


Prognostic value of baseline circulating tumor DNA levels in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
Front Immunol
Liao Y, Lin Y, Luo B, Shen J.
PMID: 41859077 [PubMed - indexed for MEDLINE]


Active Surveillance for Localized Prostate Cancer: A Retrospective Single-Center Study.
Int J Urol
Sugino A, Miyazawa Y, Nakazawa S, Tsuji Y, Fujizuka Y, Arai S, Sekine Y, Nomura M, Koike H, Matsui H, Suzuki K.
PMID: 41858140 [PubMed - indexed for MEDLINE]


Clinical Validation of the Prostate Health Index for Detecting Clinically Significant Prostate Cancer in a Population-Based Screening Program.
Int J Urol
Yaegashi H, Nakashima K, Miwa S, Miyagi T, Takashima M, Koura T, Ohno H, Kaji K, Ito K, Mizokami A.
PMID: 41858129 [PubMed - indexed for MEDLINE]


Can pelvic lymph node dissection be spared in intermediate-risk prostate cancer patients with negative PSMA PET scan? A systematic review and diagnostic meta-analysis.
Prostate Cancer Prostatic Dis
Wan QC, Min KY, Wei L, Xie LJ, Ji B.
PMID: 41857380 [PubMed - as supplied by publisher]


A prospective head-to-head comparison of (18)F-NYM005 PET/CT and (18)F-FDG PET/CT in diagnosing renal cell carcinoma.
Eur J Nucl Med Mol Imaging
Nie P, Li B, Luo L, Hou F, Zhang N, Yang H, Huang X, Zhu Z, Ma S, Wu T, Xie J, Zhang M, Yang G, Wang Z.
PMID: 41857358 [PubMed - as supplied by publisher]


Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer.
Cancer Prev Res (Phila)
Hahm ER, Jacobs BL, Singh KB, Kim SH, Parikh RA, Normolle DP, Dhir R, Oyebamiji T, Sun X, Liu Y, Appleman LJ, Gelhaus SL, Singh SV.
PMID: 41856926 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 176963    Seite 1 von 8849  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1